188 related articles for article (PubMed ID: 2468303)
21. Biochemical and immunochemical characteristics of middle ear effusions in relation to bacteriological findings.
Juhn SK; Giebink GS; Huff JS; Mills EL
Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):161-7. PubMed ID: 6778300
[TBL] [Abstract][Full Text] [Related]
22. Round window membrane in serous and purulent otitis media. Structural study in the rat.
Johansson U; Hellström S; Anniko M
Ann Otol Rhinol Laryngol; 1993 Mar; 102(3 Pt 1):227-35. PubMed ID: 8457125
[TBL] [Abstract][Full Text] [Related]
23. Effect of prostaglandin on the composition of chinchilla middle ear effusion.
Jung TT; Smith DM; Juhn SK; Gerrard JM
Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):153-60. PubMed ID: 6778299
[TBL] [Abstract][Full Text] [Related]
24. Vascular permeability of the middle ear mucosa in otitis media with effusion.
Hamaguchi Y; Juhn SK
Arch Otorhinolaryngol; 1987; 244(4):218-21. PubMed ID: 3689200
[TBL] [Abstract][Full Text] [Related]
25. [Nitric oxide and cytokines in otitis media with effusion].
Lin G; Huang W; Jiang H; Wang J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 35(1):23-5. PubMed ID: 12768683
[TBL] [Abstract][Full Text] [Related]
26. Tympanometric configurations and middle ear findings in experimental otitis media.
Giebink GS; Heller KA; Harford ER
Ann Otol Rhinol Laryngol; 1982; 91(1 Pt 1):20-4. PubMed ID: 7073172
[TBL] [Abstract][Full Text] [Related]
27. Alpha 1-antitrypsin and ilomastat inhibit inflammatory proteases present in human middle ear effusions.
Antonelli PJ; Schultz GS; Kim KM; Cantwell JS; Sundin DJ; Pemberton PA; Barr PJ
Laryngoscope; 2003 Aug; 113(8):1347-51. PubMed ID: 12897557
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil elastase-alpha 1-antitrypsin in middle ear fluid in chronic otitis media with effusion.
Tierney P; Chan B; Samuel D; Thomas M; Patel K
Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):230-3. PubMed ID: 7554333
[TBL] [Abstract][Full Text] [Related]
29. The levels of IL-1 beta in human middle ear effusions.
Juhn SK; Tolan CT; Garvis WJ; Cross DS; Giebink GS
Acta Otolaryngol Suppl; 1992; 493():37-42. PubMed ID: 1636421
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and cytological studies of immune-complex-induced otitis media in the chinchilla.
Hamaguchi Y; Juhn SK; Sakakura Y
Arch Otorhinolaryngol; 1988; 245(2):77-81. PubMed ID: 2455499
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of middle ear immune response and micronutrient level between mucoid and purulent otitis media.
Lasisi AO
J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):477-82. PubMed ID: 19755089
[TBL] [Abstract][Full Text] [Related]
32. Acute otitis media increases middle ear susceptibility to nasal injection of Pseudomonas aeruginosa.
Antonelli PJ; Juhn SK; Le CT; Giebink GS
Otolaryngol Head Neck Surg; 1994 Jan; 110(1):115-21. PubMed ID: 8290293
[TBL] [Abstract][Full Text] [Related]
33. Concentration of nitric oxide metabolites in middle ear effusion.
John EO; Russell PT; Nam BH; Jinn TH; Jung TT
Int J Pediatr Otorhinolaryngol; 2001 Jul; 60(1):55-8. PubMed ID: 11434954
[TBL] [Abstract][Full Text] [Related]
34. Experimental otitis media with effusion following middle ear inoculation of nonviable H influenzae.
DeMaria TF; Briggs BR; Lim DJ; Okazaki N
Ann Otol Rhinol Laryngol; 1984; 93(1 Pt 1):52-6. PubMed ID: 6608310
[TBL] [Abstract][Full Text] [Related]
35. [Experimental investigations on the proportional inhibitory capacity of different proteinase inhibitors in cases of chronic otitis media and cholesteatoma (author's transl)].
Kastenbauer ER; Hochstrasser K
Laryngol Rhinol Otol (Stuttg); 1978 Oct; 57(10):869-71. PubMed ID: 82895
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory changes reflected in middle ear effusion in otitis media.
Juhn SK; Jung TT
Auris Nasus Larynx; 1985; 12 Suppl 1():S63-6. PubMed ID: 3835938
[TBL] [Abstract][Full Text] [Related]
37. Lysosomal thiol proteases in middle ear effusions.
Hamaguchi Y; Sakakura K; Majima Y; Sakakura Y
Ann Otol Rhinol Laryngol Suppl; 1986; 124():9-12. PubMed ID: 3087262
[TBL] [Abstract][Full Text] [Related]
38. [Superoxide dismutase and cytokines in otitis media with effusion].
Dong W; Li Z; Zhou S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):452-4. PubMed ID: 12541690
[TBL] [Abstract][Full Text] [Related]
39. [Determination of platelet activating factor in middle ear effusion of patients with secretory oitits media].
Chen L; Huang Y; You J; Wang J; Chen Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Oct; 17(10):607-8. PubMed ID: 14727433
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan in experimental serous and purulent otitis media.
Laurent C; Hellström S; Tengblad A; Lilja K
Ann Otol Rhinol Laryngol; 1989 Sep; 98(9):736-40. PubMed ID: 2782807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
